Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.

David Charles BoettigerPairoj ChattranukulchaiAnchalee AvihingsanonRomanee ChaiwarithSuwimon KhusuwanMatthew G LawJeremy RossSasisopin Kiertiburanakul

Published in: PloS one (2021)

Reducing the recommended 10-year ASCVD risk threshold for statin initiation among PLHIV in Thailand would not currently be cost-effective. However, a lower threshold could become cost-effective with greater preference for cheaper statins.

Keyphrases

cardiovascular disease
cardiovascular events
coronary artery disease
cardiovascular risk factors
type diabetes
metabolic syndrome
low density lipoprotein